Biotechnology - CNS Diseases


Current filters:

CNS Diseases

Popular Filters

Prana reports successful Phase II results in Huntington disease trial


Australia-based Prana Biotechnology has announced positive results of its Reach2HD Phase II clinical…

AustraliaBiotechnologyCNS DiseasesNeurologicalPrana BiotechnologyResearch

Collaboration agreement between French firms Vect-Horus and AAA


French biotech company Vect-Horus has signed a scientific collaboration agreement with Advanced Accelerator…

Advanced Accelerator ApplicationsBiotechnologyCNS DiseasesEuropeLicensingMergers & AcquisitionsVect-Horus

Inovio reveals success in DNA plasmid technology

Inovio reveals success in DNA plasmid technology


US drug developer Inovio Pharmaceuticals has demonstrated the success of its new DNA plasmid technology…

Anti-Arthritics/RheumaticsBiotechnologyCNS DiseasesInovio PharmaceuticalsNorth AmericaOncologyResearch

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top